Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Open accessThe DOI matches its Crossref record; 333 of the 335 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after Alzheimer’s disease, globally. Dopaminergic neuron degeneration in substantia nigra pars compacta and aggregation of misfolded alpha-synuclein are the PD hallmarks, accompanied by motor and non-motor symptoms. Several viruses have been linked to the appearance of a post-infection parkinsonian phenotype. Coronavirus disease 2019 (COVID-19), caused by emerging severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, has evolved from a novel pneumonia to a multifaceted syndrome with multiple clinical manifestations, among which neurological sequalae appear insidious and potentially long-lasting. Exosomes are extracellular nanovesicles bearing a complex cargo of active biomolecules and playing crucial roles in intercellular communication under pathophysiological conditions. Exosomes constitute a reliable route for misfolded protein transmission, contributing to PD pathogenesis and diagnosis. Herein, we summarize recent evidence suggesting that SARS-CoV-2 infection shares numerous clinical manifestations and inflammatory and molecular pathways with PD. We carry on hypothesizing that these similarities may be reflected in exosomal cargo modulated by the virus in correlation with disease severity. Travelling from the periphery to the brain, SARS-CoV-2-related exosomal cargo contains SARS-CoV-2 RNA, viral proteins, inflammatory mediators, and modified host proteins that could operate as promoters of neurodegenerative and neuroinflammatory cascades, potentially leading to a future parkinsonism and PD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, SARS-CoV-2 directly induces AD pathogenesis such as neuronal damage and amyloid processing,278–280 as well as PD pathogenesis including α-syn aggregation and dopaminergic neuronal loss in various models.281”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [281]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–333 of 333
Tracing Cellular Origin of Human Exosomes Using Multiplex Proximity Extension Assays
Larssen, P., Wik, L., Czarnewski, P., Eldh, M., Löf, L., Ronquist, G. K., Dubois, L., Freyhult, E., Gallant, C. J., Oelrich, J., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.064725 · Cited by 127 · cited 1×
“Because of their varied cellular origin, exosomal biomolecular composition is highly heterogeneous, bearing characteristics from both surface proteins and the cargo of their donor cells [223,232].”
BackgroundRashid, F., Dzakah, E. E., Wang, H., & Tang, S. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198350 · Cited by 126 · cited 1×
“reading frame 8 (ORF8) is capable of inducing ER stress by triggering the activating transcription factor 6 (ATF6) and inositol-requiring enzymes 1 (IRE1) branches of the ER stress pathway [196], potentially leading to α-syn accumulation [197].”
BackgroundSadasivan, S., Zanin, M., O’Brien, K., Schultz-Cherry, S., & Smeyne, R. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124047 · Cited by 125 · cited 1×
“Similarly, H1N1 infection in mice resulted in persistent microglial activation as a sign of chronic virus-induced neuroinflammation that could potentially lead to neurodegeneration [54].”
BackgroundInfection and Risk of Parkinson’s Disease
Smeyne, R. J., Noyce, A. J., Byrne, M., Savica, R., & Marras, C. (2021) · Journal of Parkinson's Disease · doi:10.3233/jpd-202279 · Cited by 125
Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Xia, Y., Zhang, G., Kou, L., Yin, S., Han, C., Hu, J., Wan, F., Sun, Y., Wu, J., Li, Y., et al. (2021) · Brain · doi:10.1093/brain/awab122 · Cited by 123
Olbei, M. L., Hautefort, I., Módos, D., Treveil, A., Poletti, M., Gul, L., Shannon-Lowe, C. D., & Korcsmáros, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629193 · Cited by 120 · cited 1×
“Severe COVID-19 is characterized by a cytokine storm syndrome, which is a major cause of mortality [118,119].”
BackgroundSARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19
Peluso, M. J., Deeks, S. G., Mustapić, M., Kapogiannis, D., Henrich, T. J., Lu, S., Goldberg, S. A., Hoh, R., Chen, J. Y., Martinez, E. O., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26350 · Cited by 119 · cited 2×
“Notably, mean ADEV and NDEV levels of N protein could be used to distinguish the group of patients who developed long COVID-19 with neuropsychiatric manifestations from the long COVID-19 group without such complications and the recovered COVID-19 patients without long COVID-19 [283].”
BackgroundKandhaya‐Pillai, R., Yang, X., Tchkonia, T., Martin, G. M., Kirkland, J. L., & Oshima, J. (2022) · Aging Cell · doi:10.1111/acel.13646 · Cited by 119
Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein
Subramaniam, S. R., Vergnes, L., Franich, N. R., Reue, K., & Chesselet, M.-F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.017 · Cited by 119 · cited 1×
“In PD studies, mitochondrial dysfunction may occur months before the onset of striatal dopaminergic neuron loss [175] and PD patients have been well documented to possess reduced or deficient mitochondrial complex I activity in the SNpc [176,177].”
BackgroundMitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
Burtscher, J., Cappellano, G., Omori, A., Koshiba, T., & Millet, G. P. (2020) · iScience · doi:10.1016/j.isci.2020.101631 · Cited by 119 · cited 1×
“In this effort, SARS-CoV-2 may induce mitochondrial impairment [181,182], mitochondria-mediated oxidative stress, and mitochondrial damage through mitochondrial membrane depolarization, mitochondrial permeability transition pore opening, and enhanced ROS release [183–185].”
BackgroundThe Impact of the CD9 Tetraspanin on Lentivirus Infectivity and Exosome Secretion
Böker, K. O., Lemus-Diaz, N., Rinaldi Ferreira, R., Schiller, L., Schneider, S., & Gruber, J. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.008 · Cited by 118 · cited 2×
“For example, exosomal CD9 has been shown to be involved in the route for EV-mediated viral transmission, by speeding up lentiviral infection and improving transduction effectiveness in B- and T-lymphocytes [291].”
BackgroundCoronavirus Disease 2019 and Parkinsonism: A Non‐post‐encephalitic Case
Faber, I., Brandão, P. R. D. P., Menegatti, F., Bispo, D. D. D. C., Maluf, F. B., & Cardoso, F. (2020) · Movement Disorders · doi:10.1002/mds.28277 · Cited by 116
Omura, T., Kaneko, M., Okuma, Y., Matsubara, K., & Nomura, Y. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/239854 · Cited by 113 · cited 1×
“Endoplasmic reticulum (ER) stress has been linked to neurodegenerative diseases, including PD [190,191].”
BackgroundSi, X., Tian, J., Chen, Y., Yan, Y., Pu, J., & Zhang, B. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.015 · Cited by 111
Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson's disease.
Yf, Y., Mw, Q., Gc, L., Fb, Z., & Hc, R. (2018) · PubMed · doi:10.26355/eurrev_201808_15727 · Cited by 110 · cited 1×
“Another study in serum exosomes from PD patients observed a drop in miR-19b expression and an elevation in miR-195/miR-24 expression in PD patients compared to healthy controls [276].”
ResultER stress response plays an important role in aggregation of α-synuclein
Jiang, P., Gan, M., Ebrahim, A. S., Lin, W.-L., Melrose, H. L., & Yen, S.-H. C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-56 · Cited by 109 · cited 1×
“reading frame 8 (ORF8) is capable of inducing ER stress by triggering the activating transcription factor 6 (ATF6) and inositol-requiring enzymes 1 (IRE1) branches of the ER stress pathway [196], potentially leading to α-syn accumulation [197].”
BackgroundShin, W. H., Park, J. H., & Chung, K. C. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.283 · Cited by 104 · cited 1×
“Specifically, SARS-CoV-2-mediated deregulation of Rab7a and nucleoporin-62 (NUP62) could be strongly involved in PD pathogenesis, because Rab7 lysosomal protein decreases α-syn aggregation and associated neurotoxicity [164], while NUP62 is crucial for autophagosome development [165].”
BackgroundA Nigro−Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism
Anselmi, L., Toti, L., Bove, C., Hampton, J., & Travagli, R. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.069 · Cited by 103 · cited 1×
“The DMV is involved in the PD–neuroanatomical pathway, since a monosynaptic nigro–vagal pathway that connects the SNpc to the DMV has been identified in the rat [100].”
BackgroundSantoro, M., Maetzler, W., Stathakos, P., Martin, H. L., Hobert, M. A., Rattay, T. W., Gasser, T., Forrester, J. V., Berg, D., Tracey, K. J., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.018 · Cited by 103 · cited 2×
“Notably, inhibition of HMGB1 has been shown to reduce microglia-mediated neuroinflammation, neuron dopaminergic loss, and progression of PD pathology in PD animal models [311,312].”
BackgroundNeuroinflammation and Its Impact on the Pathogenesis of COVID-19
Almutairi, M. M., Sivandzade, F., Albekairi, T. H., Alqahtani, F., & Cucullo, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745789 · Cited by 103 · cited 1×
“Indeed, growing evidence indicates that SARS-CoV-2 induces neuroinflammation [114] through its neurotropic, neuroinvasive, and neurovirulence effects [115,116] or even via immune-mediated pathways [117].”
BackgroundProteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease
Kitamura, Y., Kojima, M., Kurosawa, T., Sasaki, R., Ichihara, S., Hiraku, Y., Tomimoto, H., Murata, M., & Oikawa, S. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.017 · Cited by 102 · cited 1×
“Furthermore, levels of clusterin, apolipoprotein A1 (apoA1), and the complement C1r subcomponent were significantly lower in PD patients at Hoehn and Yar stages II and III (a scale for assessing the functional impairment caused by PD) compared to healthy controls [268].”
BackgroundBeghi, E., Giussani, G., Westenberg, E., Allegri, R., García‐Azorín, D., Guekht, A. B., Frontera, J. A., Kivipelto, M., Mangialasche, F., Mukaetova-Ladinska, E. B., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10848-4 · Cited by 101
Long-term Risk of Parkinson Disease Following Influenza and Other Infections
Cocoros, N. M., Svensson, E., Szépligeti, S. K., Vestergaard, S. V., Szentkúti, P., Thomsen, R. W., Borghammer, P., Sørensen, H. T., & Henderson, V. W. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3895 · Cited by 101 · cited 1×
“A case-control study found that an influenza diagnosis was linked to PD development 10 years following infection onset [51], while IAV was found postmortem in the substantia nigra of PD patients [52].”
BackgroundAnosmia and Ageusia in Parkinson's Disease
Tarakad, A., & Jankovic, J. J. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.028 · Cited by 100 · cited 1×
“Indeed, both olfactory and gustatory impairments are among the earliest non-motor PD features [84,85].”
BackgroundEvidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb
Klingenstein, M., Klingenstein, S., Neckel, P. H., Mack, A. F., Wagner, A., Kleger, A., Liebau, S., & Milazzo, A. (2020) · Cells Tissues Organs · doi:10.1159/000513040 · Cited by 100 · cited 1×
“ACE2 is highly expressed in several brain areas [153], including striatum [154], the substantia nigra, the olfactory bulb [155], and the brain endothelium [130,156,157].”
BackgroundInterplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders
Paschon, V., Takada, S. H., Ikebara, J. M., de Sousa, É., Raeisossadati, R., Ulrich, H., & Kihara, A. H. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9142-1 · Cited by 99 · cited 1×
“Secondly, they can directly bind to TLRs and trigger neuroinflammation [273], and thirdly, they can induce oxidative stress pathways leading to neurotoxicity [274].”
BackgroundAlpha‐synuclein pathology in the olfactory pathways of dementia patients
Hubbard, P. S., Esiri, M. M., Reading, M., McShane, R., & Nagy, Z. (2007) · Journal of Anatomy · doi:10.1111/j.1469-7580.2007.00748.x · Cited by 99 · cited 1×
“The extent of α-syn pathology in other brain regions has been substantially linked with the pathological burden in the olfactory bulb, suggesting that PD pathology extends along olfactory pathways [90].”
BackgroundKäufer, C., Schreiber, C. S., Hartke, A.-S., Denden, I., Stanelle‐Bertram, S., Beck, S., Kouassi, N. M., Beythien, G., Becker, K., Schreiner, T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103999 · Cited by 98 · cited 1×
“Furthermore, cortical accumulation of total α-syn was observed following viral eradication in a SARS-CoV-2 intranasally-infected hamster model without any indication of inflammation and neurodegeneration [326].”
BackgroundIs severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
Mehta, P., & Fajgenbaum, D. C. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000822 · Cited by 98
SARS-CoV-2 productively infects human brain microvascular endothelial cells
Yang, R.-C., Huang, K., Zhang, H.-P., Li, L., Zhang, Y.-F., Tan, C., Chen, H.-C., Jin, M.-L., & Wang, X.-R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02514-x · Cited by 98 · cited 6×
“ACE2 is highly expressed in several brain areas [153], including striatum [154], the substantia nigra, the olfactory bulb [155], and the brain endothelium [130,156,157].”
BackgroundInfluentialDolatshahi, M., Hameghavandi, M. H. R., Sabahi, M., & Rostamkhani, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15242 · Cited by 97 · cited 1×
“Hence, deregulation of this signaling pathway has been linked to PD onset and pathology [202] by favoring α-syn accumulation, aggregation, and spreading, oxidative stress-induced neuron apoptosis, neuroinflammation, and dopaminergic neuron loss [139,203,204].”
BackgroundThe Review of “The relationship between encephalitis lethargica and influenza: A critical analysis”
McCall, S. A., Vilensky, J. A., Gilman, S., & Taubenberger, J. K. (2008) · Journal of NeuroVirology · doi:10.1080/13550280801995445 · Cited by 97 · cited 1×
“The first recorded association between viral infections and parkinsonism was observed during the Spanish flu and the appearance of encephalitis lethargica, an unknown disease with parkinsonian phenotype in survivors [41].”
BackgroundExosomes from patients with Parkinson’s disease are pathological in mice
Han, C., Xiong, N., Guo, X., Huang, J., Ma, K., Liu, L., Xia, Y. F., Shen, Y., Li, J., Jiang, H., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01810-z · Cited by 97 · cited 2×
“Serum exosomes from PD patients revealed increasing levels of IL-1 and TNF-α inflammatory mediators in comparison with the control group, while intravenous or intrastriatal administration of PD exosomes to mice induced α-syn aggregation, microglia activation, and neurodegeneration of dopaminergic neurons, leading to w…”
BackgroundSingh, K., Chen, Y.-C., Hassanzadeh, S., Han, K., Judy, J. T., Seifuddin, F., Tunc, I., Sack, M. N., & Pirooznia, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.599261 · Cited by 97 · cited 1×
“SARS-CoV-2 virulent components, such as ORF proteins, seem to modify autophagy formation and function, leading to SARS-CoV-2-induced autophagy disruption and potentially neuron damage [207,208].”
BackgroundThe involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Lashgari, N., Roudsari, N. M., Momtaz, S., Sathyapalan, T., Abdolghaffari, A. H., & Sahebkar, A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577758 · Cited by 97
SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
Fenrich, M., Mrdenovic, S., Balog, M., Tomic, S., Zjalic, M., Roncevic, A., Mandic, D., Debeljak, Z., & Heffer, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00229 · Cited by 95 · cited 1×
“A possible route allowing access to exosomes traveling long distances from peripheral tissues that are prime sites of infection, such as the intestine and the lungs, to the brain could be through retrograde axonal transport from peripheral nerves [320,321].”
BackgroundSARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia
Mishra, R., & Banerjea, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656700 · Cited by 94 · cited 1×
“MHC II overexpression, CD4 activation, and invasion of the CNS can all cause IFN-mediated phagocytic conversion of brain myeloid cells [307].”
BackgroundExtracellular Vesicles in the Pathogenesis of Viral Infections in Humans
Caobi, A., Nair, M., & Raymond, A. (2020) · Viruses · doi:10.3390/v12101200 · Cited by 92 · cited 1×
“Interestingly, many viruses, including SARS-CoV-2, have been shown to regulate exosomal biogenesis and cargo content upon release from infected host cells [35,36].”
BackgroundRowaiye, A. B., Okpalefe, O. A., Onuh, O. A., Ogidigo, J. O., Oladipo, O. H., Ogu, A. C., Oli, A. N., Olofinsae, S. A., Onyekwere, O., Abubakar, A. R., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s301784 · Cited by 92 · cited 2×
“Severe COVID-19 is characterized by a cytokine storm syndrome, which is a major cause of mortality [118,119].”
BackgroundRespiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection
Gunasekaran, M., Bansal, S., Ravichandran, R., Sharma, M., Perincheri, S., Rodriguez, F., Hachem, R., Fisher, C. E., Limaye, A. P., Omar, A., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.12.009 · Cited by 91 · cited 1×
“In the case of respiratory viruses, several studies showed that viral antigens are present in circulating exosomes recovered from lung transplant recipients infected with rhinovirus and respiratory syncytial virus [281].”
BackgroundChanges of serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 patients
Lu, Q., Zhu, Z., Tan, C., Zhou, H., Hu, Y., Shen, G., Zhu, P., Yang, G., & Xie, X. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14462 · Cited by 89
Tripathi, U., Nchioua, R., Prata, L. G. P. L., Zhu, Y., Gerdes, E. O. W., Giorgadze, N., Pirtskhalava, T., Parker, E., Xue, A., Espindola-Netto, J. M., et al. (2021) · Aging · doi:10.18632/aging.203560 · Cited by 88
Rezaie, J., Aslan, C., Ahmadi, M., Zolbanin, N. M., Kashanchi, F., & Jafari, R. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00537-0 · Cited by 88 · cited 2×
“Since exosomes have a prominent position in pathogenesis and diagnosis of neurodegenerative diseases [32] and are known to be closely linked both to viral infection establishment and infectious disease progression even after virus eradication [39,40], we aim in this review to point out and discuss potential exosome-me…”
BackgroundMitochondria Targeted Viral Replication and Survival Strategies—Prospective on SARS-CoV-2
Gatti, P., Ilamathi, H. S., Todkar, K. J., & Germain, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.578599 · Cited by 87 · cited 1×
“SARS-CoV-2 seems to interact with and manipulate mitochondria in order to hijack and evade mitochondria-mediated immune response for its own replication and survival [179,180].”
BackgroundRaghavan, S., Kenchappa, D. B., & Leo, M. D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.687783 · Cited by 87 · cited 1×
“According to in vitro studies, SARS-CoV-2 was shown to infect human BMVECs and cause a decrease in TJ protein expression [130,131].”
Pesce, E., Manfrini, N., Cordiglieri, C., Santi, S., Bandera, A., Gobbini, A., Gruarin, P., Favalli, A., Bombaci, M., Cuomo, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.785941 · Cited by 87
SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS
Li, W., Qiao, J., You, Q., Zong, S., Peng, Q., Liu, Y., Hu, S., Liu, W., Li, S., Shu, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750969 · Cited by 85 · cited 1×
“SARS-CoV-2 also appears to activate NF-κB, causing inflammation, possibly through ER stress or via interaction with the non-structural protein Nsp5 [200].”
BackgroundBellucci, A., Bubacco, L., Longhena, F., Parrella, E., Faustini, G., Porrini, V., Bono, F., Missale, C., & Pizzi, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00068 · Cited by 84 · cited 1×
“Hence, deregulation of this signaling pathway has been linked to PD onset and pathology [202] by favoring α-syn accumulation, aggregation, and spreading, oxidative stress-induced neuron apoptosis, neuroinflammation, and dopaminergic neuron loss [139,203,204].”
BackgroundInal, J. M. (2020) · Clinical Science · doi:10.1042/cs20200623 · Cited by 84 · cited 1×
“This led to the development of a competitive inhibitory therapy against SARS-CoV-2, in which ACE2-expressing EVs compete for the SARS-CoV-2 S protein S1 domain, limiting viral infection [289].”
BackgroundBrainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung
Bulfamante, G., Bocci, T., Falleni, M., Campiglio, L., Coppola, S., Tosi, D., Chiumello, D., & Priori, A. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10604-8 · Cited by 83
SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation
Reynolds, J. L., & Mahajan, S. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09975-y · Cited by 83 · cited 1×
“Furthermore, incubation of human BMVECs with S protein resulted in enhanced ACE2 expression, thereby facilitating viral entry and inducing neuroinflammation [132].”
BackgroundReview on the coronavirus disease (COVID‐19) pandemic: Its outbreak and current status
Almaghaslah, D., Kandasamy, G., Almanasef, M. A., Vasudevan, R., & Chandramohan, S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13637 · Cited by 82 · cited 1×
“The novel coronavirus SARS-CoV-2 emerged in China at the end of 2019 and triggered an outbreak of atypical viral pneumonia [61].”
BackgroundCaggiu, E., Paulus, K. S., Arru, G., Piredda, R., Sechi, G., & Sechi, L. A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.007 · Cited by 80 · cited 1×
“Additionally, it has been suggested that viruses can cause α-syn aggregation and oligomerization through molecular mimicry mechanisms [58,59].”
BackgroundHe, S., Huang, L., Shao, C., Nie, T., Xia, L., Cui, B., Lu, F., Zhu, L., Chen, B., & Yang, Q. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00249-y · Cited by 80 · cited 1×
“Finally, exosomal miRNAs were successfully used to differentially diagnose PD stages from healthy controls, showing that those miRNAs could serve as specific biomarkers both for early PD detection and PD progression [277].”
MethodJones, J. T., Qian, X., van der Velden, J. L. J., Chia, S. B., McMillan, D. H., Flemer, S., Hoffman, S. M., Lahue, K. G., Schneider, R. W., Nolin, J. D., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.03.005 · Cited by 79 · cited 1×
“Aside from initiating apoptotic pathways, ER stress is a powerful stimulator of NF-κB activation and inflammatory gene transcription [198,199].”
BackgroundAngiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
Rodriguez-Perez, A. I., Garrido‐Gil, P., Pedrosa, M. A., García-Garrote, M., Valenzuela, R., Navarro, G., Franco, R., & Labandeira-García, J. L. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.011 · Cited by 79 · cited 1×
“Another mechanism that may contribute to PD pathogenesis involves the renin– angiotensin system and ACE2, which are implicated in the pathophysiology of COVID-19 and may play a role in neuroinflammation-mediated neurodegeneration in PD [151,152].”
BackgroundUpregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Kasen, A., Houck, C., Burmeister, A. R., Sha, Q., Brundin, L., & Brundin, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105654 · Cited by 78
Sarubbo, F., Haji, K. E., Vidal-Balle, A., & Bargay, J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100399 · Cited by 77 · cited 1×
“A possible route allowing access to exosomes traveling long distances from peripheral tissues that are prime sites of infection, such as the intestine and the lungs, to the brain could be through retrograde axonal transport from peripheral nerves [320,321].”
BackgroundCOVID-19 and selective vulnerability to Parkinson's disease
Pavel, A., Murray, D., & Stoessl, A. J. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30269-6 · Cited by 76 · cited 1×
“ACE2 is highly expressed in several brain areas [153], including striatum [154], the substantia nigra, the olfactory bulb [155], and the brain endothelium [130,156,157].”
BackgroundClough, E., Inigo, J., Chandra, D., Chaves, L., Reynolds, J. L., Aalinkeel, R., Schwartz, S. A., Khmaladze, A., & Mahajan, S. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10015-6 · Cited by 75 · cited 1×
“The ensuing increase in ROS production and oxygen consumption may lead to neuroinflammation and loss of neighbor dopaminergic neurons [189].”
BackgroundCellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75 · cited 2×
“Finally, cellular senescence is a core homeostatic event that provides yet another, ageand state-dependent substrate for neurodegeneration and the development of diseases like AD and PD [141,142].”
BackgroundReview: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 75
Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
Yang, X., Li, K., Huang, H., & Ren, H. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335143 · Cited by 74 · cited 1×
“Aside from trafficking α-syn, exosomes interfere in intercellular inflammatory pathways, enhancing the possibility of PD outcomes [250].”
BackgroundVandendriessche, C., Bruggeman, A., Van Cauwenberghe, C., & Vandenbroucke, R. E. (2020) · Cells · doi:10.3390/cells9112485 · Cited by 73
Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Rao, K. V. R., & Kielian, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12237 · Cited by 73
Parkinson's Disease and Post–COVID ‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
Leta, V., Rodríguez‐Violante, M., Abundes‐Corona, A., Rukavina, K., Teo, J., Falup‐Pecurariu, C., Irincu, L., Rota, S., Bhidayasiri, R., Storch, A., et al. (2021) · Movement Disorders · doi:10.1002/mds.28622 · Cited by 73 · cited 1×
“Considering the prevalence of post-COVID-19 syndrome [81,82], a multicenter study found that 23 out of 27 PD patients developed post-COVID-19 symptoms, with the most common long term effects of COVID-19 being the deterioration of motor function and the requirement for increased levodopa daily dose, followed by fatigue…”
BackgroundMultifunctional role of exosomes in viral diseases: From transmission to diagnosis and therapy
Chaudhari, P., Ghate, V., Nampoothiri, M., & Lewis, S. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110325 · Cited by 72 · cited 1×
“Exosomes play a critical role in viral infections [278].”
BackgroundSARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro
Wu, Z., Zhang, X., Huang, Z., & Ma, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063394 · Cited by 71
Rohn, T. T., & Catlin, L. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020495 · Cited by 68 · cited 1×
“A case-control study found that an influenza diagnosis was linked to PD development 10 years following infection onset [51], while IAV was found postmortem in the substantia nigra of PD patients [52].”
BackgroundGurunathan, S., Kang, M.-H., & Kim, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716407 · Cited by 68 · cited 1×
“Interestingly, many viruses, including SARS-CoV-2, have been shown to regulate exosomal biogenesis and cargo content upon release from infected host cells [35,36].”
BackgroundPhysiological and pathological roles of exosomes in the nervous system
Yuyama, K., & Igarashi, Y. (2016) · Biomolecular Concepts · doi:10.1515/bmc-2015-0033 · Cited by 66 · cited 1×
“Exosomes, the nanosized vesicles and masters of intercellular communication [31], have been proposed to serve as an efficient “vehicle” of transportation for such proteins [32], mainly because they are a priori involved in several homeostatic procedures in the central nervous system (CNS) including myelination mainten…”
BackgroundHow Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19
Müller, L., & Benedetto, S. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212539 · Cited by 66
Greene, J. G. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5859 · Cited by 65
Srpová, B., Uher, T., Hrnčiarová, T., Barro, C., Andělová, M., Michalak, Z., Vaněčková, M., Krásenský, J., Nosková, L., Havrdová, E., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458519901272 · Cited by 65 · cited 1×
“At the same time, it has been suggested that NfL levels may potentially reflect neuroinflammatory processes leading to neurodegeneration in the early stages of multiple sclerosis development [315].”
BackgroundBordelon, Y., & Keener, A. (2016) · Seminars in Neurology · doi:10.1055/s-0036-1585097 · Cited by 64
Persistent movement disorders following Japanese encephalitis
Murgod, U. A., Muthane, U. B., Ravi, V., Radhesh, S., & Desai, A. (2001) · Neurology · doi:10.1212/wnl.57.12.2313 · Cited by 64 · cited 2×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundFan, R. Z., Guo, M., Luo, S., Cui, M., & Tieu, K. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0821-4 · Cited by 64 · cited 1×
“Other researchers used various in vitro and ex vivo cellular systems to verify the presence of α-syn in exosomes [243,244].”
BackgroundTaming the Autophagy as a Strategy for Treating COVID-19
García‐Pérez, B. E., González-Rojas, J. A., Salazar, M. I., Torres-Torres, C., & Castrejón-Jiménez, N. S. (2020) · Cells · doi:10.3390/cells9122679 · Cited by 64
Sur, S., Khatun, M., Steele, R., Isbell, T. S., Ray, R., & Ray, R. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063184 · Cited by 64 · cited 1×
“In this regard, a potential “window” of inflammatory insults to distant tissues should be examined [304].”
BackgroundAngiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells
Shi, T., Yang, F., Liu, C., Cao, X., Lü, J., Zhang, X., Yuan, M., Chen, C., & Yang, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.055 · Cited by 63 · cited 1×
“ACE2 has been suggested to regulate mitochondrial function [187].”
BackgroundParkinson’s disease or Parkinson symptoms following seasonal influenza
Toovey, S., Jick, S. S., & Meier, C. R. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00232.x · Cited by 62 · cited 1×
“Notably, the role of influenza A virus (IAV) in the etiology of the transient parkinsonian phenotype [50] and in PD development [3] has been documented in several in vivo and especially in vitro studies.”
BackgroundNew insights into the impact of neuro-inflammation in rheumatoid arthritis
Fuggle, N. R., Howe, F. A., Allen, R. L., & Sofat, N. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00357 · Cited by 62 · cited 1×
“Experimental studies in other several systemic inflammatory conditions, such as obesity [296] and rheumatoid arthritis [297], have outlined a strong relationship between peripheral systemic inflammation and neuroinflammation [298,299].”
BackgroundKumar, D., Jahan, S., Khan, A., Siddiqui, A. J., Redhu, N. S., Wahajuddin, Khan, J., Banwas, S., Alshehri, B., & Alaidarous, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02318-9 · Cited by 59 · cited 1×
“Consequently, these neuroinflammatory cascades lead to enhanced apoptotic activity, increased ROS levels, mitochondrial dysfunction, and eventually neurodegeneration [139,140].”
BackgroundTransient parkinsonism in West Nile virus encephalitis.
Robinson, R., Shahida, S., Madan, N., Rao, S.-M., & Khardori, N. (2003) · American Journal of Medicine · doi:10.1016/s0002-9343(03)00291-2 · Cited by 58 · cited 3×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundHepatitis C virus infection and risk of Parkinson’s disease: a systematic review and meta-analysis
Wijarnpreecha, K., Chesdachai, S., Jaruvongvanich, V., & Ungprasert, P. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000991 · Cited by 57 · cited 2×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundRab7 may be a novel therapeutic target for neurologic diseases as a key regulator in autophagy
Wen, H., Zhan, L., Chen, S., Long, L., & Xu, E. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24034 · Cited by 56 · cited 1×
“Specifically, SARS-CoV-2-mediated deregulation of Rab7a and nucleoporin-62 (NUP62) could be strongly involved in PD pathogenesis, because Rab7 lysosomal protein decreases α-syn aggregation and associated neurotoxicity [164], while NUP62 is crucial for autophagosome development [165].”
BackgroundAnastasi, F., Masciandaro, S. M., Carratore, R. D., Dell’Anno, M. T., Signore, G., Falleni, A., McDonnell, L. A., & Bongioanni, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062951 · Cited by 56 · cited 1×
“by the presence of L1 cell adhesion molecule (L1CAM), a surface exosomal marker highly expressed in neurons [233].”
BackgroundHomologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease
Caggiu, E., Paulus, K. S., Galleri, G., Arru, G., Manetti, R., Sechi, G., & Sechi, L. A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.004 · Cited by 54 · cited 1×
“Additionally, it has been suggested that viruses can cause α-syn aggregation and oligomerization through molecular mimicry mechanisms [58,59].”
BackgroundEffect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases
Li, D., Li, Y.-P., Li, Y.-X., Zhu, X.-H., Du, X.-G., Zhou, M., Li, W.-B., & Deng, H.-Y. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.240817 · Cited by 54 · cited 1×
“Firstly, they can inhibit protein synthesis after cellular uptake of exosomes [272].”
BackgroundStructures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets
Khan, M. T., Irfan, M., Ahsan, H., Ahmed, A., Kaushik, A. C., Khan, A. S., Chinnasamy, S., Ali, A., & Wei, D. (2021) · Intervirology · doi:10.1159/000513686 · Cited by 53 · cited 1×
“Protein trafficking, translation, transcription, and ubiquitination regulation are all coordinated by these biomolecules, leading to neuroprotection, protection of BBB integrity, and neurogenesis [166].”
BackgroundThe papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy
Mohamud, Y., Xue, Y. C., Liu, H., Ng, C. S., Bahreyni, A., Jan, E., & Luo, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.091 · Cited by 49 · cited 1×
“Interestingly, a SARS-CoV-2 papain-like protease has been identified to directly cleave serine/threonine unc-51-like kinase (ULK1) and prevent ULK1-ATG13 complex formation [211].”
BackgroundAndrade, M. C., de Faria, R. S., & Nobre, S. A. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110206 · Cited by 47
Si, X., Fang, Y., Li, L., Gu, L., Yin, X., Jun-Tian, Yan, Y., Pu, J., & Zhang, B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113525 · Cited by 47 · cited 1×
“Taken together, data from the abovementioned studies suggest that by regulating uptake and transfer of abnormal α-syn to nearby cells, exosomes are key regulators of PD pathogenesis and its spatiotemporal evolution [248,249].”
BackgroundBartolini, D., Stabile, A. M., Vacca, C., Pistilli, A., Rende, M., Gioiello, A., Cruciani, G., & Galli, F. (2021) · IUBMB Life · doi:10.1002/iub.2537 · Cited by 47 · cited 1×
“Growing evidence suggests that SARS-CoV-2 proteins interact with the ER compartment and may induce ER stress [194,195].”
BackgroundInduction and transmission of oncogene-induced senescence
Rattanavirotkul, N., Kirschner, K., & Chandra, T. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03638-0 · Cited by 43 · cited 1×
“Specifically, cell-level stressors may induce a pro-inflammatory phenotypic shift in afflicted cells, and subsequently this shift may be communicated via specific exosomal cargo in a para- and juxtracrine manner [257].”
BackgroundTao, W., Wang, X., Zhang, G., Guo, M., Ma, H., Zhao, D., Sun, Y., He, J., Liu, L., Zhang, K., et al. (2021) · Protein & Cell · doi:10.1007/s13238-020-00778-8 · Cited by 42 · cited 1×
“Importantly, other GI manifestations, such as diarrhea, emerged as common clinical symptoms of COVID-19, while SARS-CoV-2 RNA detection in fecal samples may persist post-infection [106].”
BackgroundRangon, C.-M., Krantic, S. M., Moyse, E., & Fougère, B. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200273 · Cited by 42
Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Conte, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137135 · Cited by 42 · cited 1×
“Protein-to-protein interaction between SARS-CoV-2 S protein and TLR-4 has been previously recorded [161].”
BackgroundSepúlveda, D., Cisternas-Olmedo, M., Arcos, J., Nassif, M., & Vidal, R. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805087 · Cited by 42
Parkinsonism: An emerging post COVID sequelae
Rao, A. R., Hidayathullah, S. M., Hegde, K., & Adhikari, P. (2022) · IDCases · doi:10.1016/j.idcr.2022.e01388 · Cited by 41
Herpes zoster correlates with increased risk of Parkinson's disease in older people
Lai, S., Lin, C., Lin, H.-F., Lin, C., Lin, C., & Liao, K.-F. (2017) · Medicine · doi:10.1097/md.0000000000006075 · Cited by 40 · cited 2×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundCOVID-19 - gastrointestinal and gut microbiota-related aspects.
Kaźmierczak-Siedlecka, K., Vitale, E., & Makarewicz, W. (2020) · PubMed · doi:10.26355/eurrev_202010_23448 · Cited by 39
COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress
Chaudhry, Z. L., Klenja, D., Janjua, N. A., Cami‐Kobeci, G., & Ahmed, B. Y. (2020) · Brain Sciences · doi:10.3390/brainsci10110807 · Cited by 36 · cited 2×
“Hence, deregulation of this signaling pathway has been linked to PD onset and pathology [202] by favoring α-syn accumulation, aggregation, and spreading, oxidative stress-induced neuron apoptosis, neuroinflammation, and dopaminergic neuron loss [139,203,204].”
BackgroundThe route of SARS-CoV-2 to brain infection: have we been barking up the wrong tree?
Butowt, R., & von Bartheld, C. S. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00529-9 · Cited by 36 · cited 1×
“Loaded with SARS-CoV-2 components and RNA, as well as virally-induced neuroregulatory molecules, exosomes are fully capable of accessing hard-to-reach neuroanatomical areas, such as the olfactory bulb [88], the hypothalamus [317], the DMV, and the brainstem [317–319].”
BackgroundMajde, J. A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.02.023 · Cited by 35
Role of Familial, Environmental and Occupational Factors in the Development of Parkinson’s Disease
Das, K., Ghosh, M., Nag, C., Nandy, S. P., Banerjee, M., Datta, M., Devi, G., & Chaterjee, G. (2011) · Neurodegenerative Diseases · doi:10.1159/000323797 · Cited by 33
Recent Progress on Exosomes in RNA Virus Infection
Zhang, L., Ju, Y., Chen, S. E., & Ren, L. (2021) · Viruses · doi:10.3390/v13020256 · Cited by 33 · cited 1×
“Since exosomes have a prominent position in pathogenesis and diagnosis of neurodegenerative diseases [32] and are known to be closely linked both to viral infection establishment and infectious disease progression even after virus eradication [39,40], we aim in this review to point out and discuss potential exosome-me…”
BackgroundGenetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection
Ahmed, S. S. S. J., Paramasivam, P., Kamath, S. M., Sharma, A. K., Rome, S., & Murugesan, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02485-9 · Cited by 33 · cited 1×
“The neurological consequences of SARS-CoV-2 infection, according to Ahmed and colleagues, could be attributed, at least in part, to exosomal mRNA and transcriptional factors (Tfs) carried from the lungs to the brain areas [327].”
BackgroundHofer, M. J., Li, W., Lim, S. L., & Campbell, I. L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3711-09.2010 · Cited by 31 · cited 1×
“IRF9 had been previously identified as a protective functional protein in CNS homeostasis, and its absence could result in severe neurological damage in glial cultured cells due to interferon (IFN)α-mediated overexpression of IFN-γ-like genes [305].”
BackgroundPostencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection
Espay, A. J., & Henderson, K. K. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7dd · Cited by 31 · cited 2×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundExtracellular Vesicles Regulated by Viruses and Antiviral Strategies
Yang, L., Li, J., Shen, L., Dang, W., Xin, S., Long, S., Zhang, W., Cao, P., & Lu, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722020 · Cited by 31 · cited 1×
“On top of that, findings from our group and others suggest that a virus-manipulated exosomal cargo could become a blueprint for disease progression even after the complete eradication of the viral agent, due to either immune response-related or drug-mediated viral clearance [37,38].”
BackgroundHorn, M. D., & MacLean, A. G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.695899 · Cited by 29 · cited 1×
“Given the established role of exosomes both in pathophysiological neuronal processes, and PD development and progression [294,295], as well as their emerging significance in SARS-CoV-2 infection and propagation [285], we believe that cascading from SARS-CoV-2 infection to post-COVID-19 parkinsonism and, possibly PD on…”
BackgroundPrevalence of Post COVID-19 Condition in Primary Care: A Cross Sectional Study
Montenegro, P., Moral, I., Puy, A., Cordero, E., Chantada, N., Cuixart, L., & Brotons, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031836 · Cited by 29 · cited 1×
“Considering the prevalence of post-COVID-19 syndrome [81,82], a multicenter study found that 23 out of 27 PD patients developed post-COVID-19 symptoms, with the most common long term effects of COVID-19 being the deterioration of motor function and the requirement for increased levodopa daily dose, followed by fatigue…”
BackgroundHoffman, H. K., Fernandez, M. V., Groves, N. S., Freed, E. O., & van Engelenburg, S. B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009372 · Cited by 28 · cited 9×
“Exosomal surface indicators, such as the tetraspanins CD9, CD63, and CD81, ALG 2-interacting protein X (ALIX), tumor susceptibility gene 101 protein (TSG101), and ESCRT proteins, have all been identified and used to characterize exosomes in vitro and in vivo [31].”
BackgroundInfluentialVavougios, G. D. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.071 · Cited by 28 · cited 1×
“Surprisingly, these are common early onset symptoms of COVID-19 and it has been observed that hyposmia– anosmia and dysgeusia could persist long after viral load decline, constituting a key clinical manifestation of the long COVID-19 syndrome [86,87].”
BackgroundSelf-citationCoronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
Boura, I., & Chaudhuri, К. R. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13461 · Cited by 28
Viral etiology of Parkinson's disease: Focus on influenza A virus
Yamada, T. (1996) · Parkinsonism & Related Disorders · doi:10.1016/1353-8020(96)00006-5 · Cited by 25 · cited 1×
“Although the precise mechanisms remain unclear, viruses have been implicated as potential etiological or trigger factors for both PD pathogenesis [15,16] and viral parkinsonism [4].”
BackgroundHerpes simplex virus antibodies in patients with Parkinson's disease
Marttila, R. J., & Rinne, U. K. (1978) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(78)90017-5 · Cited by 24 · cited 2×
“such as hepatitis C virus (HCV) [42], herpes simplex virus-1 (HSV-1) [43], human immunodeficiency virus (HIV) [44], varicella-zoster virus (VZV) [45], West Nile virus (WNV) [46], Japanese encephalitis virus (JEV) [47,48], and Epstein–Barr virus (EBV) [49], have all been cited as risk factors for PD development or park…”
BackgroundThe Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2
Xu, J., Wu, Z., Zhang, M., Liu, S., Zhou, L., Yang, C., & Liu, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.694446 · Cited by 24 · cited 1×
“Interestingly, the vagus nerve has been proposed as a pathway through which SARS-CoV-2 can retrogradely invade the CNS, thus enhancing its neuroinvasiveness [104,105].”
BackgroundDetection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
Canaslan, S., Schmitz, M., Villar‐Piqué, A., Maass, F., Gmitterová, K., Varges, D., Lingor, P., Llorens, F., Hermann, P., & Zerr, I. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717930 · Cited by 24
Cascading from SARS-CoV-2 to Parkinson’s Disease through Protein-Protein Interactions
Estrada, E. (2021) · Viruses · doi:10.3390/v13050897 · Cited by 23 · cited 2×
“Then, they were taken up and transported out of the lungs into the CNS by exosomes, leading to local disruption of protein–protein interactions [163].”
BackgroundCárdenas, G., Fragoso, G., & Sciutto, E. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.12.008 · Cited by 22 · cited 1×
“Indeed, growing evidence indicates that SARS-CoV-2 induces neuroinflammation [114] through its neurotropic, neuroinvasive, and neurovirulence effects [115,116] or even via immune-mediated pathways [117].”
BackgroundFYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease
Vavougios, G. D., Breza, M., Mavridis, T., & Krogfelt, K. A. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100022 · Cited by 17 · cited 1×
“Specifically, microglia and astrocytic subpopulations were enriched by inflammatory genes and deregulated neuroprotective ones that had been previously linked to PD and other human neurodegenerative diseases, such as the glial fibrillary acidic protein (GFAP), the interferoninduced transmembrane protein-3 (IFITM3), an…”
BackgroundSelf-citationWilliams, A., Branscome, H., Khatkar, P., Mensah, G. A., Sharif, S. A., Pinto, D. O., DeMarino, C., & Kashanchi, F. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00998-6 · Cited by 16 · cited 1×
“ACE2 is highly expressed in several brain areas [153], including striatum [154], the substantia nigra, the olfactory bulb [155], and the brain endothelium [130,156,157].”
BackgroundHypothalamic dysfunction in Parkinson's disease patients.
Otake, K., Oiso, Y., Mitsuma, T., Hirooka, Y., & Adachi, K. (1994) · PubMed · Cited by 15
Sur, S., Khatun, M., Steele, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.08.430369 · Cited by 14
SARS-CoV-2-induced autophagy dysregulation may cause neuronal dysfunction in COVID-19
Lakshmana, M. K. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327333 · Cited by 14 · cited 1×
“SARS-CoV-2 virulent components, such as ORF proteins, seem to modify autophagy formation and function, leading to SARS-CoV-2-induced autophagy disruption and potentially neuron damage [207,208].”
BackgroundMorowitz, J. M., Pogson, K., Roque, D., & Church, F. (2022) · Brain Sciences · doi:10.3390/brainsci12050536 · Cited by 13 · cited 1×
“In this effort, SARS-CoV-2 may induce mitochondrial impairment [181,182], mitochondria-mediated oxidative stress, and mitochondrial damage through mitochondrial membrane depolarization, mitochondrial permeability transition pore opening, and enhanced ROS release [183–185].”
BackgroundThe role of viruses in the pathogenesis of Parkinson’s disease
Baizabal-Carvallo, J., & Alonso-Juarez, M. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300437 · Cited by 12 · cited 1×
“Although the precise mechanisms remain unclear, viruses have been implicated as potential etiological or trigger factors for both PD pathogenesis [15,16] and viral parkinsonism [4].”
BackgroundNew Federal Guidance Says COVID-19’s Long-term Effects Can Qualify as a Disability
Stephenson, J. (2021) · JAMA Health Forum · doi:10.1001/jamahealthforum.2021.2820 · Cited by 3 · cited 1×
“These symptoms cannot be explained by an alternative diagnosis and are considered a disability under the Americans with Disabilities Act (ADA) [71].”
BackgroundCascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein InteractionsPreprint
Estrada, E. (2021) · Research Square · doi:10.21203/rs.3.rs-147776/v1 · Cited by 3
Karamichali, E., Foka, P., Valiakou, V., Eiliadis, P., Loukaki-Gkountara, D., Andresaki, K., Papadopoulou, G., Georgopoulou, U., & Koskinas, I.-G. (2022) · Journal of Hepatology · doi:10.1016/s0168-8278(22)00882-0 · Cited by 2 · cited 1×
“On top of that, findings from our group and others suggest that a virus-manipulated exosomal cargo could become a blueprint for disease progression even after the complete eradication of the viral agent, due to either immune response-related or drug-mediated viral clearance [37,38].”
BackgroundSelf-citationPaul, D., Mohankumar, S. K., Thomas, R. S., Kheng, C. B., & Basavan, D. (2021) · Current Drug Targets · doi:10.2174/1389450122666211103165837 · Cited by 1 · cited 1×
“Another mechanism that may contribute to PD pathogenesis involves the renin– angiotensin system and ACE2, which are implicated in the pathophysiology of COVID-19 and may play a role in neuroinflammation-mediated neurodegeneration in PD [151,152].”
Background
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“281 Previous studies have demonstrated an association between COVID-19 and long-term brain atrophy and cognitive impairment in older individuals.”
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Granholm, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093190 · Cited by 41
“Exosomes constitute a reliable route for misfolded protein transmission, contributing to the pathogenesis of neurodegenerative conditions such as PD and AD [100].”
InfluentialControversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
Surguchov, A. P., Emamzadeh, F. N., Titova, M., & Surguchev, A. A. (2023) · Biomedicines · doi:10.3390/biomedicines11041215 · Cited by 36
“An interesting hypothesis is that SARS-CoV-2 proteins are carried out as exosomal cargo together with host proteins, promoting neurodegenerative and neuroinflammatory cascades, leading to the development of synucleinopathies [86].”
BackgroundDual Role of Exosome in Neurodegenerative Diseases: A Review Study
Sheykhhasan, M., Heidari, F., Farsani, M. E., Azimzadeh, M., Kalhor, N., Ababzadeh, S., & Seyedebrahimi, R. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230726161035 · Cited by 32
Li, H., Qian, J., Wang, Y., Wang, J., Mi, X., Qu, L., Song, N., & Xie, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102288 · Cited by 23
Metadata
- Authors
- Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., Gourgoulianis, K., & Xiromerisiou, G.
- Affiliations
- University of Thessaly (GR)
- Pasteur Hellenic Institute (GR)
- 1st Neurology Department, Eginition Hospital, Medical School, National & Kapodistrian University of Athens, 11528 Athens, Greece
- Corresponding author
- Xiromerisiou, Georgia
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-08-28
- Volume
- 23
- Issue
- 17
- Pages
- 9739
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9456372
- OpenAlex
- W4293536938
- Cited by
- 25
- References
- 335
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 9
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- Parkinson's disease pathogenesis, exosomes, exosomal cargo, SARS-CoV-2, alpha-synuclein aggregation, dopaminergic neuron loss, neuroinflammation, neurodegeneration, extracellular vesicles
- MeSH terms
- COVID-19, SARS-CoV-2, Cell Communication, Humans, Parkinson Disease, RNA, Viral, Neurodegenerative Diseases, Parkinsonian Disorders, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.